Cost-effectiveness of a complex continuum of care intervention targeting women and children: protocol for an economic evaluation of the Bukhali trial in South Africa
Cost-effectiveness of a complex continuum of care intervention targeting women and children: protocol for an economic evaluation of the Bukhali trial in South Africa
Introduction
As nearly two-thirds of women presenting at their first antenatal visit are either overweight or obese in urban South Africa, the preconception period is an opportunity to optimise health and offset transgenerational risk of both obesity and non-communicable diseases. This protocol describes the planned economic evaluation of an individually randomised controlled trial of a complex continuum of care intervention targeting women and children in Soweto, South Africa (Bukhali trial).
Methods and analysis
The economic evaluation of the Bukhali trial will be conducted as a within-trial analysis from both provider and societal perspectives. Incremental costs and health outcomes of the continuum of care intervention will be compared with standard care. The economic impact on implementing agencies (programme costs), healthcare providers, participants and their households will be estimated. Incremental cost-effectiveness ratios (ICERs) will be calculated in terms of cost per case of child adiposity at age years averted. Additionally, ICERs will also be reported in terms of cost per quality-adjusted life year gained. If Bukhali demonstrates effectiveness, we will employ a decision analytical model to examine the cost-effectiveness of the intervention over a child’s lifetime. A Markov model will be used to estimate long-term health benefits, healthcare costs and cost-effectiveness. Probabilistic sensitivity analyses will be conducted to explore uncertainty and ensure robust results. An analysis will be conducted to assess the equity impact of the intervention, by comparing intervention impact within quintiles of socioeconomic status.
Ethics and dissemination
The Bukhali trial economic evaluation has ethical approval from the Human Ethics Research Committee of the University of the Witwatersrand, Johannesburg, South Africa (M240162). The results of the economic evaluation will be disseminated in a peer-reviewed journal and presented at a relevant international conference.
Palmer, Tom
383b42d4-e91a-46d7-8495-d7cdbb195c03
Granados, Rolando Leiva
61c0257f-587e-4cfd-ae00-3f4b6903eb77
Draper, Catherine
5032d1f5-0c2a-44be-8bdb-6e4967d49e14
Norris, Shane A
1d346f1b-6d5f-4bca-ac87-7589851b75a4
Batura, Neha
0fd49e97-17e5-42e2-987c-05ff97a8e87c
Palmer, Tom
383b42d4-e91a-46d7-8495-d7cdbb195c03
Granados, Rolando Leiva
61c0257f-587e-4cfd-ae00-3f4b6903eb77
Draper, Catherine
5032d1f5-0c2a-44be-8bdb-6e4967d49e14
Norris, Shane A
1d346f1b-6d5f-4bca-ac87-7589851b75a4
Batura, Neha
0fd49e97-17e5-42e2-987c-05ff97a8e87c
Palmer, Tom, Granados, Rolando Leiva, Draper, Catherine, Norris, Shane A and Batura, Neha
(2024)
Cost-effectiveness of a complex continuum of care intervention targeting women and children: protocol for an economic evaluation of the Bukhali trial in South Africa.
BMJ Open, 14 (5), [e080166].
(doi:10.1136/bmjopen-2023-080166).
Abstract
Introduction
As nearly two-thirds of women presenting at their first antenatal visit are either overweight or obese in urban South Africa, the preconception period is an opportunity to optimise health and offset transgenerational risk of both obesity and non-communicable diseases. This protocol describes the planned economic evaluation of an individually randomised controlled trial of a complex continuum of care intervention targeting women and children in Soweto, South Africa (Bukhali trial).
Methods and analysis
The economic evaluation of the Bukhali trial will be conducted as a within-trial analysis from both provider and societal perspectives. Incremental costs and health outcomes of the continuum of care intervention will be compared with standard care. The economic impact on implementing agencies (programme costs), healthcare providers, participants and their households will be estimated. Incremental cost-effectiveness ratios (ICERs) will be calculated in terms of cost per case of child adiposity at age years averted. Additionally, ICERs will also be reported in terms of cost per quality-adjusted life year gained. If Bukhali demonstrates effectiveness, we will employ a decision analytical model to examine the cost-effectiveness of the intervention over a child’s lifetime. A Markov model will be used to estimate long-term health benefits, healthcare costs and cost-effectiveness. Probabilistic sensitivity analyses will be conducted to explore uncertainty and ensure robust results. An analysis will be conducted to assess the equity impact of the intervention, by comparing intervention impact within quintiles of socioeconomic status.
Ethics and dissemination
The Bukhali trial economic evaluation has ethical approval from the Human Ethics Research Committee of the University of the Witwatersrand, Johannesburg, South Africa (M240162). The results of the economic evaluation will be disseminated in a peer-reviewed journal and presented at a relevant international conference.
Text
e080166.full
- Version of Record
More information
Submitted date: 22 September 2023
Accepted/In Press date: 26 April 2024
e-pub ahead of print date: 13 May 2024
Additional Information:
Publisher Copyright:
© 2024 BMJ Publishing Group. All rights reserved.
Identifiers
Local EPrints ID: 496835
URI: http://eprints.soton.ac.uk/id/eprint/496835
ISSN: 2044-6055
PURE UUID: 49fe1bae-06d9-4d82-a562-575c330e571c
Catalogue record
Date deposited: 08 Jan 2025 07:56
Last modified: 10 Jan 2025 03:05
Export record
Altmetrics
Contributors
Author:
Tom Palmer
Author:
Rolando Leiva Granados
Author:
Catherine Draper
Author:
Neha Batura
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics